Preliminary construction of a new rapid screening tool for SARS-CoV-2 infection from donor donors of cardiac death organs_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

WU Menghang ^1,2 ,  TANG Li ^1,2 , REN Qiuping ^1,2 , YANG Jiayin ¹ , WEN Tianfu ¹ , WU Hong ¹ , WANG Wentao ¹ , LI Bo ¹ , LUO Yanli ^1,2 , WAN Juan ^1,2 , YU Jingya ^1,2 , WU Tao ¹

1. Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, R. P. China;
2. West China Hospital of Sichuan University / West China College of Nursing, Chengdu 610041, R. P. China;

Corresponding author：

TANG Li, Email: 776716926@qq.com

Keywords：

novel coronavirus; cardiac death organ donation; liver transplantation; risk prevention and control

DOI：

10.7507/1007-9424.202003057

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To construct a rapid screening tool for the donor of heart dead organ donation (donation after circulatory death, DCD) in the background of novel coronavirus (SARS-CoV-2) infection.Methods Based on literature analysis and core group discussion, two rounds of expert consultation were carried out by Delphi method to establish dimension and index.Results The screening tool included 3 dimensions, including epidemiological history, hospital exposure history, and clinical manifestations, with 15 entries. The mean of the two rounds of expert authority coefficient was 0.757 and 0.768, and the effective recovery rate of the expert consultation questionnaire was 88% and 100%, respectively. The second round dimension and index coordination coefficients was 0.417 and 0.319, respectively. The content validity of the questionnaire was 0.91.Conclusions The DCD liver transplant donor's new rapid screening tool for SARS-CoV-2 infection is scientific and reliable. During the epidemic period, the DCD liver transplant donor risk screening tool is of great significance to the prevention and control of liver transplantation risk.

Citation： WU Menghang, TANG Li, REN Qiuping, YANG Jiayin, WEN Tianfu, WU Hong, WANG Wentao, LI Bo, LUO Yanli, WAN Juan, YU Jingya, WU Tao. Preliminary construction of a new rapid screening tool for SARS-CoV-2 infection from donor donors of cardiac death organs. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2020, 27(5): 521-526. doi: 10.7507/1007-9424.202003057 Copy

1.	央视新闻客户端. 肺炎疫情 24 小时: 党中央成立应对疫情工作领导小组 30 个省市自治区已启动一级公共卫生事件响应. 2020-01-25. http://m.news.cctv.com/2020/01/25/ARTIVdXxhUzobSvozuL6cQ44200125.shtml.
2.	Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513.
3.	Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med, 2020, 46(2): 357-360.
4.	McNeill G, Bryden D. Do either early warning systems or emergency response teams improve hospital patient survival? A systematic review. Resuscitation, 2013, 84(12): 1652-1667.
5.	沈恬, 庄莉, 孙晓东, 等. 中国肝移植受者代谢病管理专家共识(2019版). 中华移植杂志(电子版), 2019, 13(3): 187-194.
6.	新型冠状病毒感染的肺炎诊疗方案(试行第五版). 2020-02-21. http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440/files/7260301a393845fc87fcf6dd52965ecb.pdf.
7.	于长禾, 孙亚男, 何丽云, 等. 量表研制及测量属性评价标准的比较研究. 世界科学技术-中医药现代化, 2015, 17(6): 1127-1135.
8.	王春枝, 斯琴. 德尔菲法中的数据统计处理方法及其应用研究. 内蒙古财经学院学报(综合版), 2011, 9(4): 92-96.
9.	伍琳, 孙艳杰. 德尔菲法简介及在护理学中的应用现状. 护理研究, 2015, 29(29): 3599-3601.
10.	Kumar D, Tellier R, Draker R, et al. Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant, 2003, 3(8): 977-981.
11.	谢淑云, 曾光, 雷杰, 等. 一起传染性非典型肺炎爆发的“超级传播者”和传播链分析. 中华流行病学杂志, 2003, 24(6): 449-453.
12.	白浪, 王铭, 唐小琼, 等. 对新型冠状病毒肺炎诊疗中的热点问题的思考. 华西医学, 2020, 35(2): 125-131.
13.	吕涛, 杨家印, 严律南, 等. 新型冠状病毒性肺炎疫情时期器官移植调整策略及体会. 中国普外基础与临床杂志, 2020, 27(3): 261-264.
14.	Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020, 382(13): 1199-1207.
15.	Kumar D, Manuel O, Natori Y, et al. COVID-19: a global transplant perspective on successfully navigating a pandemic. Am J Transplant, 2020 Mar 23. [Epub ahead of print].
16.	新型冠状病毒肺炎诊疗方案(试行第六版). 2020-02-19. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf.
17.	陈燕雅, 齐蒙蒙, 李泽楷. 护理本科生职业相关社会支持量表的编制及信效度检验. 护理管理杂志, 2017, 17(10): 723-726.
18.	史静琤, 莫显昆, 孙振球. 量表编制中内容效度指数的应用. 中南大学学报(医学版), 2012, 37(2): 49-52.

1. 央视新闻客户端. 肺炎疫情 24 小时: 党中央成立应对疫情工作领导小组 30 个省市自治区已启动一级公共卫生事件响应. 2020-01-25. http://m.news.cctv.com/2020/01/25/ARTIVdXxhUzobSvozuL6cQ44200125.shtml.
2. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513.
3. Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med, 2020, 46(2): 357-360.
4. McNeill G, Bryden D. Do either early warning systems or emergency response teams improve hospital patient survival? A systematic review. Resuscitation, 2013, 84(12): 1652-1667.
5. 沈恬, 庄莉, 孙晓东, 等. 中国肝移植受者代谢病管理专家共识(2019版). 中华移植杂志(电子版), 2019, 13(3): 187-194.
6. 新型冠状病毒感染的肺炎诊疗方案(试行第五版). 2020-02-21. http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440/files/7260301a393845fc87fcf6dd52965ecb.pdf.
7. 于长禾, 孙亚男, 何丽云, 等. 量表研制及测量属性评价标准的比较研究. 世界科学技术-中医药现代化, 2015, 17(6): 1127-1135.
8. 王春枝, 斯琴. 德尔菲法中的数据统计处理方法及其应用研究. 内蒙古财经学院学报(综合版), 2011, 9(4): 92-96.
9. 伍琳, 孙艳杰. 德尔菲法简介及在护理学中的应用现状. 护理研究, 2015, 29(29): 3599-3601.
10. Kumar D, Tellier R, Draker R, et al. Severe acute respiratory syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant, 2003, 3(8): 977-981.
11. 谢淑云, 曾光, 雷杰, 等. 一起传染性非典型肺炎爆发的“超级传播者”和传播链分析. 中华流行病学杂志, 2003, 24(6): 449-453.
12. 白浪, 王铭, 唐小琼, 等. 对新型冠状病毒肺炎诊疗中的热点问题的思考. 华西医学, 2020, 35(2): 125-131.
13. 吕涛, 杨家印, 严律南, 等. 新型冠状病毒性肺炎疫情时期器官移植调整策略及体会. 中国普外基础与临床杂志, 2020, 27(3): 261-264.
14. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020, 382(13): 1199-1207.
15. Kumar D, Manuel O, Natori Y, et al. COVID-19: a global transplant perspective on successfully navigating a pandemic. Am J Transplant, 2020 Mar 23. [Epub ahead of print].
16. 新型冠状病毒肺炎诊疗方案(试行第六版). 2020-02-19. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf.
17. 陈燕雅, 齐蒙蒙, 李泽楷. 护理本科生职业相关社会支持量表的编制及信效度检验. 护理管理杂志, 2017, 17(10): 723-726.
18. 史静琤, 莫显昆, 孙振球. 量表编制中内容效度指数的应用. 中南大学学报(医学版), 2012, 37(2): 49-52.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Preliminary construction of a new rapid screening tool for SARS-CoV-2 infection from donor donors of cardiac death organs

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content